706 related articles for article (PubMed ID: 27917531)
1. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
[TBL] [Abstract][Full Text] [Related]
2. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
[TBL] [Abstract][Full Text] [Related]
3. [Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over].
Mick G; Gallais JL; Simon F; Pinchinat S; Bloch K; Beillat M; Serradell L; Derrough T
Rev Epidemiol Sante Publique; 2010 Dec; 58(6):393-401. PubMed ID: 21094001
[TBL] [Abstract][Full Text] [Related]
4. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.
Takao Y; Miyazaki Y; Okeda M; Onishi F; Yano S; Gomi Y; Ishikawa T; Okuno Y; Mori Y; Asada H; Yamanishi K; Iso H
J Epidemiol; 2015; 25(10):617-25. PubMed ID: 26399445
[TBL] [Abstract][Full Text] [Related]
5. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.
Friesen KJ; Chateau D; Falk J; Alessi-Severini S; Bugden S
BMC Infect Dis; 2017 Jan; 17(1):69. PubMed ID: 28086817
[TBL] [Abstract][Full Text] [Related]
6. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study.
Amirthalingam G; Andrews N; Keel P; Mullett D; Correa A; de Lusignan S; Ramsay M
Lancet Public Health; 2018 Feb; 3(2):e82-e90. PubMed ID: 29276017
[TBL] [Abstract][Full Text] [Related]
8. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
Cho SI; Lee CH; Park GH; Park CW; Kim HO
J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
[TBL] [Abstract][Full Text] [Related]
9. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
10. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study.
Forbes HJ; Bhaskaran K; Thomas SL; Smeeth L; Clayton T; Mansfield K; Minassian C; Langan SM
Neurology; 2016 Jul; 87(1):94-102. PubMed ID: 27287218
[TBL] [Abstract][Full Text] [Related]
11. Burden of herpes zoster and post-herpetic neuralgia in Sweden.
Nilsson J; Cassel T; Lindquist L
BMC Infect Dis; 2015 May; 15():215. PubMed ID: 26002038
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
13. Peptic ulcer as a risk factor for postherpetic neuralgia in adult patients with herpes zoster.
Chen JY; Lan KM; Sheu MJ; Tseng SF; Weng SF; Hu ML
J Med Virol; 2015 Feb; 87(2):222-9. PubMed ID: 25156435
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.
Lu WH; Lin CW; Wang CY; Chen LK; Hsiao FY
BMC Public Health; 2018 Mar; 18(1):369. PubMed ID: 29554872
[TBL] [Abstract][Full Text] [Related]
15. Herpes zoster and postherpetic neuralgia in older adults.
Schmader K
Clin Geriatr Med; 2007 Aug; 23(3):615-32, vii-viii. PubMed ID: 17631237
[TBL] [Abstract][Full Text] [Related]
16. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
17. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.
Drolet M; Brisson M; Schmader KE; Levin MJ; Johnson R; Oxman MN; Patrick D; Blanchette C; Mansi JA
CMAJ; 2010 Nov; 182(16):1731-6. PubMed ID: 20921251
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
[TBL] [Abstract][Full Text] [Related]
19. The burden of herpes zoster and postherpetic neuralgia in the United States.
Weaver BA
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
[TBL] [Abstract][Full Text] [Related]
20. [Herpes zoster in old adults].
Lang PO; Belmin J; Michel JP
Presse Med; 2009 Apr; 38(4):571-83. PubMed ID: 19028069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
